VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESGO 2021 | KORE Innovation trial: an enhanced perioperative pathway for patients with ovarian cancer

Jalid Sehouli, MD, Charité University of Medicine Berlin, Berlin, Germany, discusses the rationale behind the KORE Innovation Trial, a European initiative in patients with gynecological malignancies. This study is an open, prospective, multicentric, interventional study that will implement and evaluate an enhanced perioperative pathway for patients with ovarian cancer. This interview took place at the European Society of Gynaecological Oncology (ESGO) 2021 congress in Prague.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter